The US Food and Drug Administration said it has authorized emergency use of Actemra to treat adult and pediatric COVID-19 patients in hospitals, and an emergency use authorization has been issued to Genentech, a unit of Roche Holdings Inc. The Food and Drug Administration said the drug could be used …
Read More »Novavax Says Its Vaccine is 90% Effective Against Coronavirus
Biotech company Novavax said today that its COVID-19 vaccine has been shown to be 90.4% safe and effective overall in phase 3 clinical trials for nearly 30,000 participants across the United States and Mexico. Also, it was found that the two-dose vaccine is 100% effective in preventing moderate and severe …
Read More »Britain: Talks With AstraZeneca About The Vaccine to Combat Beta COVID-19 Variant
British Health Minister Matt Hancock said Wednesday, June 2 that his country is in talks with Oxford and AstraZeneca to obtain additional doses of their vaccine against the Corona virus, which has been modified to better target the (beta) strain of the emerging corona virus that first appeared in South …
Read More »Moderna: The Effectiveness of The Corona Vaccine in Children Between 12 and 17 Years Has Reached 100%
Moderna said its vaccine for Covid-19 was 100% effective in a study of adolescents aged 12-17 years as the second vaccine after Pfizer to prove highly effective in younger age groups. The company is seeking FDA approval by next June.
Read More »Canadian Province of Alberta Confirms First Death Related to AstraZeneca Vaccine – Reuters
The head of the medical sector in the Canadian province of Alberta said in a statement that the province witnessed the first death related to the AstraZeneca vaccine against Covid-19 disease. Late on Tuesday, he said that a woman in her 50s had died after being injected with the vaccine. …
Read More »AstraZeneca Reports Earnings Per Share of $1.19 in Q1 2021, up 100% Year-on-Year
AstraZeneca reported a 100% year-on-year increase in earnings per share for Q1 of 2021, to $1.19. The company achieved strong revenue growth of 15% in Q1 of 2021 to $7.3 billion, excluding a contribution from the pandemic vaccine COVID-19, revenue growth increased by 11% to $7.04 billion.
Read More »European Union v. AstraZeneca Case Begins in Brussels
A court in Brussels has begun hearing a lawsuit filed by the European Commission against the pharmaceutical company AstraZeneca over supplies of its Covid-19 vaccine, as the cartel’s lawyers are pressing for immediate delivery of doses from all factories, including those in Britain. The case is the latest turning point …
Read More »Japan to Declare COVID-19 State of Emergency in Tokyo, Osaka Region
Japanese stocks closed lower on Friday, April 23, as tighter government restrictions to contain COVID-19 infections raised concerns about the economy’s recovery, while disappointing expectations from nedec reinforced the cautious atmosphere at the start of the corporate earnings announcements season. The Nikkei index fell 0.57% to close at 29020.63 points, …
Read More »U.S. to Halt Johnson & Johnson’s vaccine
Health authorities in the United States on Tuesday recommended stopping the use of the Johnson & Johnson’s coronavirus vaccine, Reuters reported. Hopes were high for the single-dose vaccine, however, it was recently reported that six females under the age of 50 years developed rare blood clots after receiving the shot. …
Read More »US Recommends Pause For Johnson & Johnson COVID-19 Vaccines Over Clot Reports
The US Food and Drug Administration said it is asking states to temporarily stop using Johnson & Johnson’s Covid-19 vaccine after 6 people in the United States developed a rare blood clotting disorder. The US Food and Drug Administration said the recommendation “results from an abundance of caution,” adding that …
Read More »